These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2462522)
1. Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice. Silverman M; Ilardi C; Bank S; Kranz V; Lendvai S Gastroenterology; 1989 Jan; 96(1):186-92. PubMed ID: 2462522 [TBL] [Abstract][Full Text] [Related]
2. Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice. Ohshio G; Saluja A; Leli U; Sengupta A; Steer ML Pancreas; 1989; 4(6):739-43. PubMed ID: 2813332 [TBL] [Abstract][Full Text] [Related]
3. Effects of the cholecystokinin receptor antagonist L-364,718 on pancreatitis induced by a deficient in choline and supplemented with ethionine (CDE) diet in the rat. Manso MA; Rodriguez AI; Garcia-Montero AC; De Dios I Arch Physiol Biochem; 1995 Aug; 103(4):410-5. PubMed ID: 8548474 [TBL] [Abstract][Full Text] [Related]
4. Effects of the specific cholecystokinin antagonist L 364,718 in experimental acute pancreatitis in the rat. Sjövall S; Ahrén B; Stenram U Eur Surg Res; 1988; 20(5-6):325-9. PubMed ID: 2465158 [TBL] [Abstract][Full Text] [Related]
5. The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation. Nordback IH; Clemens JA; Cameron JL Surgery; 1991 Mar; 109(3 Pt 1):301-6. PubMed ID: 1705726 [TBL] [Abstract][Full Text] [Related]
6. Action of CCK on CDE diet-induced acute pancreatitis in rats treated with hydrocortisone. Manso MA; Rebollo A; Pescador R; de Dios I Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jun; 111(2):257-63. PubMed ID: 8521247 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. Niederau C; Liddle RA; Ferrell LD; Grendell JH J Clin Invest; 1986 Oct; 78(4):1056-63. PubMed ID: 2428840 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis. Garcia-Montero AC; Manso MA; Rodriguez AI; De Dios I Pancreas; 1994 May; 9(3):309-15. PubMed ID: 7517544 [TBL] [Abstract][Full Text] [Related]
10. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice]. Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301 [TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas. Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728 [TBL] [Abstract][Full Text] [Related]
12. Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats. Otsuki M; Tani S; Okabayshi Y; Nakamura T; Fujii M; Fujisawa T; Baba S; Itoh H Pancreas; 1989; 4(2):237-43. PubMed ID: 2474165 [TBL] [Abstract][Full Text] [Related]
13. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors. Vasar E; Stephenson JD; Meldrum BS Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160 [TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin augmentation of 'surgical' pancreatitis. Benefits of receptor blockade. Modlin IM; Bilchik AJ; Zucker KA; Adrian TE; Sussman J; Graham SM Arch Surg; 1989 May; 124(5):574-8. PubMed ID: 2469410 [TBL] [Abstract][Full Text] [Related]
15. Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis. Niederau C; Niederau M; Borchard F; Ude K; Lüthen R; Strohmeyer G; Ferrell LD; Grendell JH Pancreas; 1992; 7(4):486-96. PubMed ID: 1641391 [TBL] [Abstract][Full Text] [Related]
16. Involvement of cholecystokinin receptors in the adverse effect of glucocorticoids on diet-induced necrotizing pancreatitis. Gomez G; Townsend CM; Green D; Rajaraman S; Uchida T; Thompson JC Surgery; 1989 Aug; 106(2):230-6; discussion 237-8. PubMed ID: 2474863 [TBL] [Abstract][Full Text] [Related]
17. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models. Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042 [TBL] [Abstract][Full Text] [Related]
18. Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. Gomez G; Townsend CM; Green DW; Rajaraman S; Uchida T; Greeley GH; Soloway RD; Thompson JC J Clin Invest; 1990 Jul; 86(1):323-31. PubMed ID: 1694866 [TBL] [Abstract][Full Text] [Related]
19. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats. Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461 [TBL] [Abstract][Full Text] [Related]